Elan, Mayo Settle Patent Dispute Over Transgenic Mouse

Law360, New York (November 12, 2004, 12:00 AM EST) -- Irish drug maker Elan Corporation, PLC and the U.S.-based Mayo Foundation for Medical Education and Research have settled their long-running patent dispute over a type of mouse used in research on Alzheimer's disease.

The settlement agreement resolves a patent dispute regarding certain transgenic mice patents and facilitates use by both parties of an array of research tools in combating the disease, Elan and Mayo said in a joint statement.

“The resolution of this dispute provides Mayo and Elan with cross-licenses necessary to pursue their respective ongoing...
To view the full article, register now.